TherapeuticsMD, Inc.
TherapeuticsMD, Inc. (TXMD): 3 pipeline candidates · 3 upcoming catalysts · ~22 mo cash runway. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
21.7 months
D/E 0.39 · 0% dilution
Lead: Approved
3 candidates
3 upcoming, next in ~2348d
1 buy · 0 sells (180d)
A transparent, data-derived signal for TherapeuticsMD, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$26.3M
Cash
$8.4M
Quarterly Burn
$1.4M
Runway
21.7 mo
Revenue
$724K
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (3 candidates)
Upcoming Catalysts (3)
Loss of exclusivity — patent/exclusivity expiry opens the door to generic or biosimilar competition that can erode revenue.
Loss of exclusivity — patent/exclusivity expiry opens the door to generic or biosimilar competition that can erode revenue.
Loss of exclusivity — patent/exclusivity expiry opens the door to generic or biosimilar competition that can erode revenue.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
47
Total value held
$4.8M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 707,394 | $1.4M |
| clearline capital lp | 635,222 | $1.3M |
| adar1 capital management, llc | 209,210 | $423K |
| renaissance technologies llc | 146,200 | $295K |
| morgan stanley | 129,217 | $261K |
| blackrock, inc. | 115,145 | $233K |
| geode capital management, llc | 109,817 | $222K |
| citadel advisors llc | 95,114 | $192K |
| vanguard fiduciary trust co | 63,831 | $129K |
| state street corp | 30,100 | $61K |
Showing top 10 of 47 institutional holders of TherapeuticsMD, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in TherapeuticsMD, Inc.'s pipeline?
TherapeuticsMD, Inc. (TXMD) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is TherapeuticsMD, Inc.'s lead drug candidate?
TherapeuticsMD, Inc.'s most advanced tracked candidate is annovera (Approved) for prevent pregnancy.
What is TherapeuticsMD, Inc.'s next catalyst?
TherapeuticsMD, Inc.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: BIJUVA" — expected November 21, 2032.
What is TherapeuticsMD, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, TherapeuticsMD, Inc. has approximately 21.7 months of cash runway.
What is TherapeuticsMD, Inc.'s market capitalization?
TherapeuticsMD, Inc.'s market capitalization is approximately $26.3M.
Get the full picture on TherapeuticsMD, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.